Together these studies support the function of Kindlin-2 as a major regulator of several key hallmarks of cancer37,38; and make a strong argument for the development of therapeutic strategies to target Kindlin-2 in BC as well as other cancers. This evidence concerns the gene FERMT2 and breast cancer.